Cargando…
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
Immunotherapy has developed rapidly in solid tumors, especially in the areas of blocking inhibitory immune checkpoints and adoptive T-cell transfer for immune regulation. Many patients benefit from immunotherapy. However, the response rate of immunotherapy in the overall population are relatively lo...
Autores principales: | Zhang, Jiaxin, Wang, Siyuan, Zhang, Daidi, He, Xin, Wang, Xue, Han, Huiqiong, Qin, Yanru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435760/ https://www.ncbi.nlm.nih.gov/pubmed/37600822 http://dx.doi.org/10.3389/fimmu.2023.1230893 |
Ejemplares similares
-
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
por: Chen, Chen, et al.
Publicado: (2022) -
Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors
por: Yang, Fan, et al.
Publicado: (2023) -
Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023) -
Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
por: Yang, Rou, et al.
Publicado: (2023) -
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)